Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Live and let live.

Kutikuppala Surya Rao1

  • 1Harvard University, USA.

Journal of the Indian Medical Association
|June 10, 2003
PubMed
Summary

Developing an accessible HIV/AIDS vaccine is crucial for global prevention, as stigma and current therapies remain insufficient. Complexities exist in conducting vaccine trials, especially in developing nations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Gynandroblastoma: a rare ovarian tumour with an unusual clinical presentation.

Journal of the Indian Medical Association·2015
Same journal

Bilateral hip and knee arthroplasty in ochronotic arthritis.

Journal of the Indian Medical Association·2015
Same journal

Biliary colic with dilated common bile duct: simple "sheepish" problem?

Journal of the Indian Medical Association·2015
Same journal

Proximal femoral focal deficiency revisited: a case report.

Journal of the Indian Medical Association·2015
Same journal

Disseminated intra-abdominal hydatid disease: surgical management.

Journal of the Indian Medical Association·2015
Same journal

Eosinophilic ascitis, an unusual presentation of eosinophilic gastro-enteritis.

Journal of the Indian Medical Association·2015

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • World AIDS Day, established by WHO in 1988, highlights the global HIV/AIDS epidemic, with 40-50 million people affected globally.
  • Stigma and discrimination present significant barriers to effective HIV/AIDS prevention strategies worldwide.
  • Highly Active Antiretroviral Therapy (HAART) has not eradicated Human Immunodeficiency Virus (HIV), underscoring the need for alternative prevention methods.

Purpose of the Study:

  • To emphasize the critical need for a globally accessible Human Immunodeficiency Virus (HIV) vaccine.
  • To acknowledge the persistent challenges in HIV/AIDS prevention and treatment.
  • To address the complexities inherent in conducting AIDS vaccine efficacy trials, particularly in resource-limited settings.

Main Methods:

  • Literature review on global HIV/AIDS statistics and prevention challenges.
  • Analysis of the limitations of current HIV therapies like Highly Active Antiretroviral Therapy (HAART).
  • Discussion of the ethical and logistical considerations for AIDS vaccine trials in developing countries.

Main Results:

  • The global HIV/AIDS burden remains substantial, with 40-50 million individuals affected.
  • Existing treatments (HAART) do not eliminate HIV, highlighting the need for preventive measures.
  • Significant obstacles to HIV prevention include societal stigma and discrimination.

Conclusions:

  • A globally accessible Human Immunodeficiency Virus (HIV) vaccine represents the most promising strategy for long-term prevention.
  • Overcoming stigma and discrimination is essential for effective HIV/AIDS control.
  • Conducting robust AIDS vaccine efficacy trials in developing nations requires careful planning and consideration of unique challenges.

Related Experiment Videos